BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rocha BML, Menezes Falcão L. Acute decompensated heart failure (ADHF): A comprehensive contemporary review on preventing early readmissions and postdischarge death. Int J Cardiol 2016;223:1035-44. [PMID: 27592046 DOI: 10.1016/j.ijcard.2016.07.259] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang J, Xie L, Chen X, Lyu P, Zhang Q. Changes in Laminin in Acute Heart Failure. Int Heart J 2022;63:454-8. [PMID: 35650146 DOI: 10.1536/ihj.21-769] [Reference Citation Analysis]
2 Huang R, Wang Z, Chen J, Bao X, Xu N, Guo S, Gu R, Wang W, Wei Z, Wang L. Prognostic value of triglyceride glucose (TyG) index in patients with acute decompensated heart failure. Cardiovasc Diabetol 2022;21:88. [PMID: 35641978 DOI: 10.1186/s12933-022-01507-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Saito Y, Nakai T, Ikeya Y, Kogawa R, Otsuka N, Wakamatsu Y, Kurokawa S, Ohkubo K, Nagashima K, Okumura Y. Clinical significance of the albumin–bilirubin score in patients with heart failure undergoing cardiac resynchronization therapy. Heart Vessels. [DOI: 10.1007/s00380-021-02008-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Tamaki S, Yamada T, Watanabe T, Morita T, Kawasaki M, Kikuchi A, Kawai T, Seo M, Nakamura J, Kayama K, Sakamoto D, Ueda K, Kogame T, Tamura Y, Fujita T, Nishigaki K, Fukuda Y, Kokubu Y, Fukunami M. Usefulness of the 2-year iodine-123 metaiodobenzylguanidine-based risk model for post-discharge risk stratification of patients with acute decompensated heart failure. Eur J Nucl Med Mol Imaging 2022. [PMID: 34997293 DOI: 10.1007/s00259-021-05663-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Usuda D, Higashikawa T, Hotchi Y, Usami K, Shimozawa S, Tokunaga S, Osugi I, Katou R, Ito S, Yoshizawa T, Asako S, Mishima K, Kondo A, Mizuno K, Takami H, Komatsu T, Oba J, Nomura T, Sugita M. Angiotensin receptor blocker neprilysin inhibitors. WJC 2021;13:326-40. [DOI: 10.4330/wjc.v13.i8.326] [Reference Citation Analysis]
6 Usuda D, Higashikawa T, Hotchi Y, Usami K, Shimozawa S, Tokunaga S, Osugi I, Katou R, Ito S, Yoshizawa T, Asako S, Mishima K, Kondo A, Mizuno K, Takami H, Komatsu T, Oba J, Nomura T, Sugita M. Angiotensin receptor blocker neprilysin inhibitors. World J Cardiol 2021; 13(8): 325-339 [PMID: 34589168 DOI: 10.4330/wjc.v13.i8.325] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Lorenzo M, Palau P, Llàcer P, Domínguez E, Ventura B, Núñez G, Miñana G, Solsona J, Santas E, De La Espriella R, Bodí V, Núñez E, Sanchis J, Bayés-Genís A, Núñez J. Clinical utility of antigen carbohydrate 125 for planning the optimal length of stay in acute heart failure. Eur J Intern Med 2021:S0953-6205(21)00196-5. [PMID: 34130879 DOI: 10.1016/j.ejim.2021.05.037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Clark H, Rana R, Gow J, Pearson M, van der Touw T, Smart N. Hospitalisation costs associated with heart failure with preserved ejection fraction (HFpEF): a systematic review. Heart Fail Rev 2021. [PMID: 33765251 DOI: 10.1007/s10741-021-10097-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kawahira M, Tamaki S, Yamada T, Watanabe T, Morita T, Furukawa Y, Kawasaki M, Kikuchi A, Kawai T, Seo M, Nakamura J, Kayama K, Kimura T, Ueda K, Sakamoto D, Kogame T, Ito S, Chang Y, Fukunami M. Prognostic value of impaired hepato-renal function and liver fibrosis in patients admitted for acute heart failure. ESC Heart Fail 2021;8:1274-83. [PMID: 33472273 DOI: 10.1002/ehf2.13195] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
10 Wang J, Zhou W, Yin X. Improvement of hyponatremia is associated with lower mortality risk in patients with acute decompensated heart failure: a meta-analysis of cohort studies. Heart Fail Rev 2019;24:209-17. [PMID: 30535839 DOI: 10.1007/s10741-018-9753-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
11 Kuriyama A, Urushidani S. Continuous versus intermittent administration of furosemide in acute decompensated heart failure: a systematic review and meta-analysis. Heart Fail Rev 2019;24:31-9. [PMID: 30054781 DOI: 10.1007/s10741-018-9727-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
12 Aamodt IT, Lycholip E, Celutkiene J, von Lueder T, Atar D, Falk RS, Hellesø R, Jaarsma T, Strömberg A, Lie I. Self-Care Monitoring of Heart Failure Symptoms and Lung Impedance at Home Following Hospital Discharge: Longitudinal Study. J Med Internet Res 2020;22:e15445. [PMID: 31909717 DOI: 10.2196/15445] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
13 Delgado JF, Ferrero Gregori A, Fernández LM, Claret RB, Sepúlveda AG, Fernández-avilés F, González-juanatey JR, García RV, Otero MR, Segovia Cubero J, Pascual Figal D, Crespo-leiro MG, Alvarez-garcía J, Cinca J, Ynsaurriaga FA. Patient-Associated Predictors of 15- and 30-Day Readmission After Hospitalization for Acute Heart Failure. Curr Heart Fail Rep 2019;16:304-14. [DOI: 10.1007/s11897-019-00442-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
14 Tamaki S, Yamada T, Morita T, Furukawa Y, Iwasaki Y, Kawasaki M, Kikuchi A, Kawai T, Seo M, Abe M, Nakamura J, Yamamoto K, Kayama K, Kawahira M, Tanabe K, Ueda K, Kimura T, Sakamoto D, Fukunami M. Prognostic Value of Calculated Plasma Volume Status in Patients Admitted for Acute Decompensated Heart Failure - A Prospective Comparative Study With Other Indices of Plasma Volume. Circ Rep 2019;1:361-71. [PMID: 33693164 DOI: 10.1253/circrep.CR-19-0039] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
15 Miró Ò, Rossello X, Gil V, Martín-sánchez FJ, Llorens P, Herrero-puente P, Jacob J, Piñera P, Mojarro EM, Lucas-imbernón FJ, Llauger L, Agüera C, López-díez MP, Valero A, Bueno H, Pocock SJ, Gil MF, Salvo E, Escoda R, Aguiló S, Xipell C, Sánchez C, Gaytan JM, Noval A, Torres JM, Valero A, Aguirre A, Pedragosa MÀ, Torres-gárate R, Alonso MI, Ruiz F, Franco JM, Sánchez S, Alquézar A, Rizzi MA, Herrera S, Cabello I, Roset Á, Alonso H, Adrada ER, García GL, Álvarez Pérez JM, Mecina AB, Álvarez JV, González MS, Prieto B, García MG, Marquina V, Jiménez I, Javaloyes P, Hernández N, Brouzet B, López A, Andueza JA, Romero R, Calvache R, Lorca MT, Calderón L, Arriaga BA, Sierra B, Piñera P, Sánchez Nicolás JA, Mojarro EM, Bécquer LT, García LL, La Salle GC, Urbano CA, Ferrer ES. Analysis of How Emergency Physicians’ Decisions to Hospitalize or Discharge Patients With Acute Heart Failure Match the Clinical Risk Categories of the MEESSI-AHF Scale. Annals of Emergency Medicine 2019;74:204-15. [DOI: 10.1016/j.annemergmed.2019.03.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
16 Rocha BML, Cunha GJL, Menezes Falcão LF. The Burden of Iron Deficiency in Heart Failure: Therapeutic Approach. J Am Coll Cardiol 2018;71:782-93. [PMID: 29447741 DOI: 10.1016/j.jacc.2017.12.027] [Cited by in Crossref: 45] [Cited by in F6Publishing: 57] [Article Influence: 15.0] [Reference Citation Analysis]
17 Örsçelik Ö, Özkan B, Arslan A, Şahin EE, Sakarya O, Sürmeli OA, Balcı Fidancı Ş, Çelik A, Çimen BY, Özcan İT. Relationship between intrarenal renin-angiotensin activity and re-hospitalization in patients with heart failure with reduced ejection fraction. Anatol J Cardiol 2018;19:205-12. [PMID: 29521315 DOI: 10.14744/AnatolJCardiol.2018.68726] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
18 Tehrani B, Truesdell A, Singh R, Murphy C, Saulino P. Implementation of a Cardiogenic Shock Team and Clinical Outcomes (INOVA-SHOCK Registry): Observational and Retrospective Study. JMIR Res Protoc 2018;7:e160. [PMID: 29954728 DOI: 10.2196/resprot.9761] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]